Unknown

Dataset Information

0

Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.

ABSTRACT:

SUBMITTER: Goletti D 

PROVIDER: S-EPMC7944951 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.

Goletti Delia D   Cantini Fabrizio F  

The New England journal of medicine 20210301 9

Similar Datasets

Unknown Unmet need for COVID-19 vaccination coverage in Kenya.
| S-EPMC8841160 | biostudies-literature
Unknown Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
| S-EPMC7313480 | biostudies-literature
Unknown Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
| S-EPMC7250091 | biostudies-literature
Unknown Current Status of Baricitinib as a Repurposed Therapy for COVID-19.
| S-EPMC8308612 | biostudies-literature
Unknown Met and unmet need for mental health care before and during the COVID-19 pandemic.
| S-EPMC8522377 | biostudies-literature
Unknown Stem cell therapy for COVID-19 pneumonia.
| S-EPMC8850486 | biostudies-literature
Unknown Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis.
| S-EPMC8253716 | biostudies-literature
Unknown Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study.
| S-EPMC9243240 | biostudies-literature
Unknown Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects.
| S-EPMC11129021 | biostudies-literature
Unknown Baricitinib: From Rheumatoid Arthritis to COVID-19.
| S-EPMC8250677 | biostudies-literature